Ceribell (CBLL) Notes Payables (2023)
Ceribell's (CBLL) quarterly Notes Payables came in at $11.8 million in Q4 2023.
Analysis
Ceribell (CBLL) Notes Payables (2023) Analysis & Trends
Ceribell (CBLL) has reported Notes Payables for 1 consecutive years, with $11.8 million the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Notes Payables changed N/A year-over-year to $11.8 million; the trailing twelve-month figure through Dec 2023 stood at $11.8 million (changed N/A YoY), and the FY2023 full-year result was $11.8 million, changed N/A from the prior year.
- Notes Payables was little changed at $11.8 million in Q4 2023 per CBLL's latest filing.
- Across five years, Notes Payables topped out at $11.8 million in Q4 2023 and bottomed at $11.8 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn |